| Literature DB >> 28973645 |
Sabrina M Heman-Ackah1,2,3, Raquel Manzano4, Jeroen J M Hoozemans5, Wiep Scheper6,7, Rowan Flynn8, Wilfried Haerty9, Sally A Cowley8, Andrew R Bassett10, Matthew J A Wood4.
Abstract
The recent generation of induced pluripotent stem cells (iPSCs) from a patient with Parkinson's disease (PD) resulting from triplication of the α-synuclein (SNCA) gene locus allows unprecedented opportunities to explore its contribution to the molecular pathogenesis of PD. We used the double-nicking CRISPR/Cas9 system to conduct site-specific mutagenesis of SNCA in these cells, generating an isogenic iPSC line with normalized SNCA gene dosage. Comparative gene expression analysis of neuronal derivatives from these iPSCs revealed an ER stress phenotype, marked by induction of the IRE1α/XBP1 axis of the unfolded protein response (UPR) and culminating in terminal UPR activation. Neuropathological analysis of post-mortem brain tissue demonstrated that pIRE1α is expressed in PD brains within neurons containing elevated levels of α-synuclein or Lewy bodies. Having used this pair of isogenic iPSCs to define this phenotype, these cells can be further applied in UPR-targeted drug discovery towards the development of disease-modifying therapeutics.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28973645 PMCID： PMC5886237 DOI： 10.1093/hmg/ddx331
Source DB: PubMed Journal: Hum Mol Genet ISSN： 0964-6906 Impact factor: 6.150